Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable.

Abstract : The beneficial metabolic actions of estrogen-based therapies are mainly mediated by estrogen receptor α (ERα), a nuclear receptor that regulates gene transcription through two activation functions (AFs): AF-1 and AF-2. Using mouse models deleted electively for ERαAF-1 (ERαAF-1°) or ERαAF-2 (ERαAF-2°), we determined their respective roles in the actions of estrogens on body composition and glucose homeostasis in response to either a normal diet or a high-fat diet (HFD). ERαAF-2° males and females developed accelerated weight gain, massive adiposity, severe insulin resistance, and glucose intolerance--quite reminiscent of the phenotype observed in mice deleted for the entire ERα protein (ERα(-/-)). In striking contrast, ERαAF-1° and wild-type (wt) mice shared a similar metabolic phenotype. Accordingly, 17β-estradiol administration regulated key metabolic genes in insulin-sensitive tissues and conferred a strong protection against HFD-induced metabolic disturbances in wt and ERαAF-1° ovariectomized mice, whereas these actions were totally abrogated in ERαAF-2° and ERα(-/-) mice. Thus, whereas both AFs have been previously shown to contribute to endometrial and breast cancer cell proliferation, the protective effect of estrogens against obesity and insulin resistance depends on ERαAF-2 but not ERαAF-1, thereby delineating new options for selective modulation of ERα.
Type de document :
Article dans une revue
Diabetes, American Diabetes Association, 2013, 62 (12), pp.4098-108. 〈10.2337/db13-0282〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00852314
Contributeur : Marie Francoise Simon <>
Soumis le : mardi 20 août 2013 - 15:50:13
Dernière modification le : vendredi 27 avril 2018 - 10:22:01

Lien texte intégral

Identifiants

Collections

Citation

Sandra Handgraaf, Elodie Riant, Aurelie J Fabre, Aurélie Waget, Rémy Burcelin, et al.. Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable.. Diabetes, American Diabetes Association, 2013, 62 (12), pp.4098-108. 〈10.2337/db13-0282〉. 〈inserm-00852314〉

Partager

Métriques

Consultations de la notice

212